Shilpa Dhar Murthy

Amikacin liposome inhalation suspension clinical benefit–risk assessment for refractory Mycobacterium avium complex lung disease

T. Marras, M. Ciesielska, Z. Jumadilova, 2022, ERJ Open Research.

Amikacin Liposome Inhalation Suspension Clinical Benefit-Risk Assessment for Refractory MAC Lung Disease

T. Marras, Bpharm, M. Ciesielska, 2022 .